1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. ATS Mycobacterial Diseases Subcommittee. American Thoracic Society. Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007. 175:367–416.
Article
2. Duttaroy B, Agrawal C, Pendse A. Spinal tuberculosis due to dissemination of atypical mycobacteria. Indian J Med Sci. 2004. 58:203–205.
3. Petitjean G, Fluckiger U, Scharen S, Laifer G. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect. 2004. 10:951–953.
Article
4. Yano T, Okuda S, Kato K, Kato K, Kishimoto T.
Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy. Intern Med. 2004. 43:1084–1086.
Article
5. Meybeck A, Fortin C, Abgrall S, Adle-Biassette H, Hayem G, Ruimy R, Yeni P. Spondylitis due to
Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature. J Clin Microbiol. 2005. 43:1465–1466.
Article
6. Tortoli E, Mantella A, Mariottini A, Mazzarelli G, Pecile P, Rogasi PG, Sterrantino G, Fantoni E, Leoncini F. Successfully treated spondylodiscitis due to a previously unreported mycobacterium. J Med Microbiol. 2006. 55:119–121.
Article
7. Corrales-Medina V, Symes S, Valdivia-Arenas M, Boulanger C. Localized
Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapy. South Med J. 2006. 99:174–177.
Article
8. Korres DS, Papagelopoulos PJ, Zahos KA, Kolia MD, Poulakou GG, Falagas ME. Multifocal spinal and extra-spinal
Mycobacterium chelonae osteomyelitis in a renal transplant recipient. Transpl Infect Dis. 2007. 9:62–65.
Article
9. Danaviah S, Govender S, Gordon ML, Cassol S. Atypical mycobacterial spondylitis in HIV-negative patients identified by genotyping. J Bone Joint Surg Br. 2007. 89:346–348.
Article
10. Sobottke R, Zarghooni K, Seifert H, Faetkenheuer G, Koriller M, Michael JW, Delank KS, Eysel P. Spondylodiscitis caused by Mycobacterium xenopi. Arch Orthop Trauma Surg. 2008. 128:1047–1053.
11. Hirakawa A, Miyamoto K, Ohno Y, Hioki A, Ogawa H, Nishimoto H, Yokoi T, Hosoe H, Shimizu K. Two-stage (posterior and anterior) surgical treatment of spinal osteomyelitis due to atypical mycobacteria and associated thoracolumbar kyphoscoliosis in a nonimmunocompromised patient. Spine (Phila Pa 1976). 2008. 33:E221–E224.
Article
12. Wong NM, Sun LK, Lau PY. Spinal infection caused by
Mycobacterium avium complex in a patient with no acquired immune deficiency syndrome: a case report. J Orthop Surg (Hong Kong). 2008. 16:359–363.
Article
13. Rahman I, Bhatt H, Chillag S, Duffus W. Mycobacterium chelonae vertebral osteomyelitis. South Med J. 2009. 102:1167–1169.
14. Takakuwa O, Oguri T, Kasai D, Nakamura A, Sato S, Ueda R. A case of spinal osteomyelitis due to Mycobacterium intracellulare with pulmonary Mycobacterium avium complex. Nihon Kokyuki Gakkai Zasshi. 2010. 48:759–764.
15. Kim BH, Park JS, Jang YR, Kim JY, Cho YK. A case of Mycobacterium abscessus spondylitis. Korean J Med. 2012. 83:277–282.
16. Chan ED, Kong PM, Fennelly K, Dwyer AP, Iseman MD. Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: 3 examples of the principle of locus minoris resistentiae. Clin Infect Dis. 2001. 32:1506–1510.
Article
17. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against
Mycobacterium fortuitum,
Mycobacterium chelonae, and
M. chelonae-like organisms. Antimicrob Agents Chemother. 1992. 36:180–184.
Article
18. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of
Mycobacterium fortuitum biovar. fortuitum and the two subgroups of
Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991. 35:773–775.
Article
19. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to
Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985. 152:500–514.
Article
20. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004. 364:369–379.
Article